kubsv (@kubsv) profile picture
New York, USA
Joined February 2009
Photo by kubsv (@kubsv)Photo by kubsv (@kubsv)Photo by kubsv (@kubsv)Photo by kubsv (@kubsv)Photo by kubsv (@kubsv)Photo by kubsv (@kubsv)Photo by kubsv (@kubsv)Photo by kubsv (@kubsv)Photo by kubsv (@kubsv)Photo by kubsv (@kubsv)
$CTMX CytomX Therapeutics Announces Milestone Achievement in Strategic Collaboration with Regeneron in the Field of Conditionally Activated Bispecifics
1
1
389
kubsv retweeted
$FRMI LEOPOLD ASCHENBRENNER'S SITUATIONAL AWARENESS DISCLOSES NEW $332.6M NEBIUS CALL POSITION, $182.7M SANDISK CALLS, $140.3M DRAM ETF CALLS AND 2.67M FERMI SHARES IN Q3 13F
7
4
3
49
15,167
$LUMN - Sec. Duffy says working with Lumen, VZ, T on Architecture
2
266
kubsv retweeted
$GEO linked to 10 deaths, lawmakers call for contract terminations EXCLUSIVE: BOMBSHELL ICE INVESTIGATION EXPOSES SUBSTANDARD MEDICAL CARE IN DETAINEE DEATHS, WITH GEO GROUP FACILITIES LINKED TO 10 CASES - SF CHRONICLE LAWMAKERS CALL FOR CONTRACTOR PENALTIES AND POSSIBLE CONTRACT TERMINATIONS - SF CHRONICLE
3
3
1
10
6,307
$HYFT MindWalk Announces Agreement with Teva Australia to Support Defined Antibody-Discovery Workflows. Multi-year agreement covers a defined deployment of ReefIQ™ and specified LensAI™ capabilities
306
$ALOY REalloys and U.S. Army Execute Term Sheet for Heavy Rare Earth Processing Facility at Tooele Army Depot
1
411
$ALOY term sheet sets out the principal terms for a potential long-term Enhanced Use Lease of up to 75 years to develop domestic dysprosium and terbium processing on a U.S. defense installation
2
199
$KAZR The merger will be scrapped as part of the new plan to take Kaz Resources public. But Skyline shareholders will still own more than a quarter of the company once it is listed, leaving investors including the Trumps with stakes.
1
405
$NFE New Fortress Energy Inc. (NASDAQ: NFE) today announced that it has agreed to lease ten mobile turbines that can generate up to 300 megawatts of power to a US-based investment-grade company. The lease is for an initial period of five years. The turbines are expected to be delivered in stages beginning in the fourth quarter of 2026 and finalized in the first quarter of 2027. The transaction is expected to be accretive to NFE’s earnings and enhance its liquidity profile.
455
$WKHS Workhorse Enters Modular AI Infrastructure Market Through Foundational TerraPod™ Partnership with UK-Based RHAELM
333
$CHRS Coherus Oncology Announces Compelling Tagmokitug Interim Clinical Data in Esophageal Cancer and Path to Advance Development
4
603
$HTOO EXCLUSIVE: Fusion Fuel Green Said Its UAE Subsidiary Contracted 87 LPG Engineering Projects Worth ~AED19.2M (~$5.2M) ; Expands UAE Footprint
221
$MNTS NASA Awards Task Order Contract to Momentus for Mission Formulation Phase of Fly Foundational Robots Resupply Mission
238
$QS QuantumScape Announces Plans for 100 MWh Solid-State Battery Production Line for AI Data Centers, Aerospace and Defense
1
6
495
$NEXR Nexera Technologies: Fort Technology’s Subsidiary Logia USA Signs Exclusive Distribution Agreement to Expand Fuel Maintenance Solutions for Data Centers Across the U.S.
213
$INO INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that it secured a judgment in its favor, in the amount of $80,416,101, on all claims it filed against defendants VGXI, Inc. ("VGXI") and GeneOne Life Science, Inc. ("GeneOne") in the case captioned INOVIO Pharmaceuticals, Inc. v. VGXI, Inc. and GeneOne Life Science, Inc
513
$VIR $GILD Vir Biotechnology Enters Multi-Program Collaboration and License Agreement with Gilead Sciences to Discover and Develop Novel PRO-XTEN® Dual-masked T-cell Engagers for Solid Tumors. Vir Biotechnology will be eligible to receive up to $135 million in total upfront and near-term preclinical milestone payments, consisting of $90 million in upfront consideration, which includes $65 million in cash and a $25 million equity investment at a 30% premium, and up to $45 million in potential near-term preclinical milestones. In addition, Vir Biotechnology has the potential to receive up to $1.74 billion in further development, regulatory and commercial milestones, along with tiered high single-digit to low double-digit royalties on net sales.
4
299
$AUUD Since the original record date, Auddia has experienced a significant expansion in strategic momentum, driven primarily by the emergence of LT350, a subsidiary of Thramann Holdings that would become a subsidiary of MCFN upon closing of the proposed merger. LT350 is developing a patented distributed datacenter platform designed to meet rapidly growing AI inference demand. LT350’s architecture deploys datacenter grade GPU infrastructure in the airspace of existing parking lots, a structural advantage that directly addresses the community resistance bottlenecks slowing datacenter expansion nationwide. This momentum has carried over to LT350 gaining national and local attention as a common sense solution to the community resistance issues facing other data centers as evidenced by recent appearances on Fox Business News’ Varney & Co., Bloomberg News Network, Fox 17 Nashville, as well as multiple interviews with print outlets. This has accelerated the initiation of discussions with several strategic partners across fiber, real estate, enterprise, and hyperscaler ecosystems. These developments have materially increased both the clarity and magnitude of the LT350 opportunity underlying the merger.
2
2
302
$AUUD invested in LT350 - CNBC interview
245